HLE Glascoat Limited has informed the Exchange about Investor Presentation
HLEGLAS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
HLE Glascoat reported FY26 consolidated revenue of ₹1,353.0 Cr, up 31.7% YoY, but profitability declined significantly. EBITDA grew only 5.4% to ₹148.5 Cr (margin fell from 13.7% to 11.0%), while PAT fell 8.4% to ₹56.6 Cr (margin from 6.0% to 4.2%). The Q4 FY26 performance showed similar pressure with PAT down 36.3% YoY. The newly acquired Omeras Germany business (acquired Aug 2025) contributed an EBITDA loss of ₹15.3 Cr and PAT loss of ₹15.6 Cr due to transition challenges. One-time costs of ₹2.1 Cr (new Labour Codes) and ₹4.6 Cr (acquisition costs) also weighed on results. The company has a strong order book of ₹681.6 Cr (10 months for international, 4 months for India business), providing revenue visibility. Total debt-to-equity improved to 0.51 from 0.63 a year ago.
Margin compression due to Omeras acquisition costs and one-time expenses is a near-term headwind, but a healthy order book of ₹681.6 Cr and the company's diversified product portfolio across pharma, agrochemicals, and specialty chemicals support long-term revenue growth. The stock may face near-term pressure due to declining PAT margins despite strong topline growth.